Overview

"Physiological" Insulin Scheme vs Traditional Scheme for Glycemic Control in Non-critical Hospitalized Patients With Diabetes Mellitus 2

Status:
Completed

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to determine differences in glycemic control between a traditional regimen with Neutral Protamine Hagedorn insulin (NPH) and a "physiological" regimen or basal bolus regimen with glargine and lispro insulin in a population of hospitalized patients with type 2 diabetes in a Noncritical Care Facility. Patients with a recent diagnosis of type 2 and patients on treatment with oral hypoglycaemic agents and insulin or only insulin were included. The primary outcome of the study is to determine difference in efficacy and security between the treatment groups as measured by the mean daily blood glucose (efficacy is normoglycemia and number of days in glycemic control during the hospital stay; security is hypoglycemic events and complication diabetes mellitus associated).

Phase:

Phase 4

Details

Lead Sponsor:

Universidad de Guanajuato

Treatments:

Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human